Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-12-20 16:11:47
Oslo, Norway, December 20, 2022 - Reference is made to the announcement made by
Nykode Therapeutics ASA on December 18, 2022 regarding exercise of warrants by a
primary insider. The share capital increase has now been registered with the
Norwegian Register of Business Enterprises, and the company's new share capital
is NOK 2,939,043.09, divided into 293,904,309 shares, each with a par value of
NOK 0.01.